Trial reportFrontiers in endocrinology2025
Telehealth insulin titration in adults with diabetes: a randomized controlled trial comparing bluetooth-enabled versus traditional glucometers.
Trial report in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Blood glucose self-monitoring is crucial for individuals with diabetes mellitus and on insulin therapy to ensure safe glycemic control and optimal treatment outcomes. This study evaluates the effectiveness of Bluetooth-enabled glucometers (BTG) versus Traditional glucometers (TG) in a telehealth insulin titration program for individuals with diabetes. Methods: This 24-week, open-label, randomized controlled trial enrolled 120 participants with diabetes from a tertiary hospital. Participants, aged 21-70 years, who required either insulin initiation or intensification were randomly assigned to either the BTG or TG group. Both groups received three biweekly teleconsultations with Diabetes Nurse Educators for insulin dose adjustments, followed by two clinic visits at three-month intervals. Results: Participants were predominantly male, Chinese, and diagnosed with Type 2 diabetes. Both groups demonstrated significant reductions in glycated hemoglobin (HbA1c) throughout the study. The TG group achieved HbA1c reductions of 2.8% at Week 12 and 3.1% at Week 24 (both Conclusion: BTG did not demonstrate glycemic superiority over TG in telehealth insulin titration; however, its association with reduced emergency department visits suggests potential benefits for healthcare utilization. Future studies should investigate the integration of BTG with comprehensive diabetes care platforms, with a focus on long-term outcomes and cost-effectiveness. Clinical Trial Registration: https://www.isrctn.com/ISRCTN69173566, Identifier: ISRCTN69173566.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.